Featured Research

from universities, journals, and other organizations

Simple amoeba holds the key to better treatment for Alzheimer's disease

Date:
January 24, 2014
Source:
University of Royal Holloway London
Summary:
Scientists have discovered the use of a simple single-celled amoeba to understand the function of human proteins in causing Alzheimer’s disease.

This image shows Dictyostelium amoeba.
Credit: Royal Holloway University

Scientists have discovered the use of a simple single-celled amoeba to understand the function of human proteins in causing Alzheimer's disease.

The new study, published in the Journal of Cell Science today (Friday 24 January) by researchers at Royal Holloway, University of London and the Institute of Psychiatry King's College London, reveals how the amoeba will enable a better understanding of the function of these Alzheimer's disease-associated proteins in the cell without the need for testing on animals, with the ultimate aim of developing improved treatments for the degenerative disease.

Mutations in presenilin proteins cause inherited forms of Alzheimer's disease, and these proteins also play a major role in the age-related onset of the condition.

However, understanding the role of these proteins is difficult, since cells lacking the proteins are non-viable.

Presenilin proteins have been extensively analyzed and animals are commonly used in this research area, but these experiments are problematic since deletion of the proteins in animal cells causes a loss of viability and blocks the development.

"This discovery allows us to examine the role for the human presenilin 1 protein, without the use of animal testing. It is amazing that so simple an organism lends itself to the study of such a complex disease," says Professor Robin Williams from the School of Biological Sciences at Royal Holloway.

"This work on the amoeba Dictyostelium shows we can successfully use this simple model to try to better understand the normal roles of other proteins and genes involved in Alzheimer's disease and other forms of neurodegeneration," added Dr Richard Killick from the Institute of Psychiatry King's College London.


Story Source:

The above story is based on materials provided by University of Royal Holloway London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ludtmann, Otto, Schilde, Chen, Allan, Brace, Beesley, Kimmel, Fisher, Killick and Williams. An ancestral non-proteolytic role for presenilin proteins in multicellular development of the social amoeba Dictyostelium discoideum. Journal of Cell Science, January 2014

Cite This Page:

University of Royal Holloway London. "Simple amoeba holds the key to better treatment for Alzheimer's disease." ScienceDaily. ScienceDaily, 24 January 2014. <www.sciencedaily.com/releases/2014/01/140124082704.htm>.
University of Royal Holloway London. (2014, January 24). Simple amoeba holds the key to better treatment for Alzheimer's disease. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2014/01/140124082704.htm
University of Royal Holloway London. "Simple amoeba holds the key to better treatment for Alzheimer's disease." ScienceDaily. www.sciencedaily.com/releases/2014/01/140124082704.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins